Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Uterine Cervical Neoplasms × Misoprostol × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasm Metastasis 5 Myofibroma 5 Hemorrhage 4 Leiomyoma 3 Blood Loss, Surgical 3 Uterine Cervical Neoplasms 1 Myoma 1 Diabetes Insipidus 1

Interventions

Cisplatin 99 Radiotherapy 53 Brachytherapy 41 Paclitaxel 37 Carboplatin 36 Surveys and Questionnaires 28 Blood Specimen Collection 20 pembrolizumab 19 Radiation 17 Magnetic Resonance Spectroscopy 16 Drug Therapy 16 Colposcopy 16 Methods 14 Bevacizumab 14 Early Intervention, Educational 12 toripalimab 11 Topotecan 11 Radiotherapy, Intensity-Modulated 11 Papanicolaou Test 11 Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 11 Biopsy 11 Mass Screening 10 Gemcitabine 10 Chemoradiotherapy 10 camrelizumab 9 Patient Navigation 9 Papillomavirus Vaccines 9 Fluorodeoxyglucose F18 9 Educational Status 9 Docetaxel 9

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06669533 2025-10-01

MISOPCx

University of Alabama at Birmingham

Phase NA Recruiting

Uterine Cervical Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡